CABOZANTINIB
cabozantinib 60 mg tablet, 30
CABOZANTINIB (14224P)
14224P
Manner of administration:Oral
Restriction 15454
Indication: Locally advanced or metastatic differentiated thyroid cancer
Treatment phase: Initial treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 30 | # of repeats: 2 | DPMQ: $9,472.93 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Cabometyx | |||||